AI Verdict
RNST has stronger fundamentals based on our AI analysis.
RNST vs RNAC Fundamental Comparison
| Metric | RNST | RNAC |
|---|---|---|
| Revenue | $1.3B | $2.8M |
| Net Income | $181.3M | $-130.3M |
| Net Margin | 14.4% | -4,658.6% |
| ROE | 4.7% | N/A |
| ROA | 0.7% | -44.0% |
| Current Ratio | N/A | 8.65x |
| Debt/Equity | 0.13x | N/A |
| EPS | $2.07 | $-5.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RNST vs RNAC: Frequently Asked Questions
Is RNST or RNAC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RNST has stronger fundamentals. RNST is rated HOLD (70% confidence) while RNAC is rated STRONG SELL (85% confidence). This is not investment advice.
How does RNST compare to RNAC fundamentally?
RENASANT CORP has ROE of 4.7% vs Cartesian Therapeutics, Inc.'s N/A. Net margins are 14.4% vs -4,658.6% respectively.
Which stock pays higher dividends, RNST or RNAC?
RNST has a dividend yield of N/A or no dividend while RNAC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RNST or RNAC for long term?
For long-term investing, consider that RNST has HOLD rating with 70% confidence, while RNAC has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RNST vs RNAC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RNST vs RNAC, the AI consensus favors RNST based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.